Beyond IVF: Eugenics and Reproductive Biotechnology
By Jennifer Denbow,
Nursing Clio
| 10. 31. 2024
Access to in vitro fertilization (IVF) has emerged as a crucial issue in the 2024 election. While the Republican Party Platform claims support for access to IVF, many backers of Donald Trump and Project 2025 have pushed for restrictions on IVF. The Republican-backed Life at Conception Act would declare that an embryo is a human being from “the moment of fertilization.” If it passes, it would endanger IVF treatments across the country. As Senator, Trump’s vice-presidential candidate JD Vance voted against the opposing Right to IVF Act. In contrast, Kamala Harris has committed to access to IVF.
While IVF should absolutely be legally protected, politicians and public commentators should not flatten discussions of reproductive biotechnology as a simple choice between access and restriction. What is missing from this debate is the complex terrain that prospective parents have to navigate regarding reproductive genetic technologies. Over the past 25 years, biotechnology companies have rapidly developed a range of reproductive technologies, from non-invasive prenatal testing to polygenic embryo screening. Companies and researchers claim that other genetic detection, selection, and editing tools are on...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...